Raphael Pharmaceutical (RAPH) Cash & Equivalents (2020 - 2026)
Raphael Pharmaceutical (RAPH) reported Cash & Equivalents of $1,000 for Q2 2026, down 95.0% from $20,000 a year earlier.
Powered by 
Analysis
Raphael Pharmaceutical (RAPH) Cash & Equivalents (2020 - 2026) Analysis & Trends
At the end of FY2025, Raphael Pharmaceutical posted Cash & Equivalents of $45,000, up 136.8% from FY2024.
- Cash & Equivalents has a five-year compound annual growth rate of -13.9% (FY2020 to FY2025).
- By year, Cash & Equivalents came in at $19,000 in FY2024 (-91.7%), $230,000 in FY2023 (-20.1%), $288,000 in FY2022 (+88.2%) and $153,000 in FY2021 (+61.1%).
- The Q2 2026 figure ranks as the lowest quarterly Cash & Equivalents in data going back to Q4 2020.
- Year over year, Cash & Equivalents gained in 1 of the last seven quarters, with an average decline of 56.4%.
- The high point for year-over-year Cash & Equivalents in five years was Q1 2024 (growth of 655.3%); the low point was Q2 2026 (a decline of 95.0%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 20.42 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 6.57 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 6.85 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 7.62 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 4.89 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 13.99 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 3.18 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 976.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 6.14 Bn |
| 10 | Raphael Pharmaceutical | 28.25 Mn | 28.18 Mn | - | 1,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1,000.00 |
| Dec 31, 2025 | 45,000.00 |
| Sep 30, 2025 | 3,000.00 |
| Jun 30, 2025 | 20,000.00 |
| Mar 31, 2025 | 50,000.00 |
| Dec 31, 2024 | 19,000.00 |
| Sep 30, 2024 | 40,000.00 |
| Jun 30, 2024 | 120,000.00 |
| Mar 31, 2024 | 287,000.00 |
| Dec 31, 2023 | 230,000.00 |
| Sep 30, 2023 | 299,000.00 |
| Jun 30, 2023 | 111,000.00 |
| Mar 31, 2023 | 38,000.00 |
| Dec 31, 2022 | 288,000.00 |
| Sep 30, 2022 | 93,000.00 |
| Jun 30, 2022 | 135,000.00 |
| Mar 31, 2022 | 81,000.00 |
| Dec 31, 2021 | 153,000.00 |
| Sep 30, 2021 | 37,000.00 |
| Dec 31, 2020 | 95,000.00 |
API Access
Raphael Pharmaceutical Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=RAPH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "RAPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=RAPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();